Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data

• Auteurs principaux: Chengcheng Gong (Auteur), Yizhao Xie (Auteur), Yannan Zhao (Auteur), Yi Li (Auteur), Jian Zhang (Auteur), Leiping Wang (Auteur), Jun Cao (Auteur), Zhonghua Tao (Auteur), Xichun Hu (Auteur), Biyun Wang (Auteur)
• Format: Livre
• Publié: SAGE Publishing, 2022-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Purpose: Weekly gemcitabine + paclitaxel (wGT) administration is widely applied in real-world clinical practice. The 28-day and 21-day regimens of wGT are the most widely accepted regimens. We evaluated the efficacy and safety of wGT administration in patients with metastatic breast cancer (MBC) and...